ProCE Banner Activity

Weekly Insulin: Translating the Latest Evidence Into Practical Considerations

Clinical Thought

Expert faculty discusses the benefits and disadvantages of weekly basal insulin and once approved, how to fit weekly basal insulin into the treatment paradigm for patients with type 2 diabetes.

Released: September 26, 2023

Expiration: September 26, 2024

Share

Faculty

Steven V. Edelman

Steven V. Edelman, MD

Clinical Professor of Medicine
Division of Endocrinology and Metabolism
Department of Medicine
University of California, San Diego
San Diego, California

Provided by

Provided by Clinical Care Options, LLC in partnership with the Endocrine Society.

ProCE Banner

Supporters

This activity is supported by an educational grant from Novo Nordisk. 

Novo Nordisk

Partners

Endocrine Society

ProCE Banner

Faculty Disclosure

Primary Author

Steven V. Edelman, MD

Clinical Professor of Medicine
Division of Endocrinology and Metabolism
Department of Medicine
University of California, San Diego
San Diego, California

Steven V. Edelman, MD: consultant: AstraZeneca, BrightSight, Lilly, MannKind, Sanofi-Aventis, Seneonics.